drugset / Trial / NCT03136965
Platelet-Rich Plasma Therapy for Patellar Tendinopathy
RandomizedParallel-groupDouble-blindTreatment
Summary
The overall goal of this research is to find an effective treatment for patellar tendinopathy (PT). To achieve this, we will conduct a double-blinded randomized controlled trial to investigate if platelet-rich plasma is effective for treatment. Clinical (pain and function scores) and bio-mechanical (knee strength) measures will be correlated with disease modification changes assessed using conventional and novel quantitative magnetic resonance imaging (MRI) and ultrasound (US) techniques.
Timeline
- Start
- 2017-04-25
- Primary completion
- 2022-08-15
- Completion
- 2022-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Platelet Rich Plasma | Other / unclassified | 5 ml | Other |